title: [Epidemiology, clinical features, and evolution of Erysipelas in the Marrakech region (100 cases)].
abstract: OBJECTIVE
  We aimed to determine the epidemiological and clinical profile, and to study the evolution of this disease in the Marrakech region.
  
  
  METHODS
  We retrospectively studied all patients with a diagnosis of erysipelas admitted in the Department of Dermatology from 1990 to 2002, in the Marrakech Mohamed VI hospital.
  
  
  RESULTS
  A total of 100 patients were included in the study, 58 male (58%) and 42 female (42%) patients, age range 9-95 years (mean age: 47 years). The lesions were most frequently located on the lower limbs (87% of the cases), with 82 cases occurring in the legs, whereas the face was affected in 10% of the cases. Erysipelas relapsed in 12 patients (12%). All patients had at least one risk factor: portal of entry (80 cases, with 67 cases of toe web intertrigo), obesity (10% of the cases), lymphedema (6% of the cases), diabetes (3% of the cases). The first line treatment was intravenous penicillin G in 76 cases (76%). Satisfactory results were observed in 78% of the cases.
  
  
  CONCLUSIONS
  Erysipelas is common in hospital environment. An early penicillin therapy associated to the treatment of the portal of entry leads to satisfactory results.
authors.affiliation: Service de dermatovénérologie, faculté de médecine, CHU Mohamed-VI, BP 7010, Sidi Abbad, Marrakech 40000, Maroc. amal@fmpm.ac.ma
authors.forename: S
authors.initials: S
authors.lastname: Amal
authors.forename: S
authors.initials: S
authors.lastname: Houass
authors.forename: K
authors.initials: K
authors.lastname: Laissaoui
authors.forename: K
authors.initials: K
authors.lastname: Moufid
authors.forename: M
authors.initials: M
authors.lastname: Trabelsi
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002648:Child; D016021:Epidemiologic Studies; D004886:Erysipelas / Q000188:drug therapy / Q000453:epidemiology* / Q000473:pathology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009018:Morocco / Q000453:epidemiology; D010400:Penicillin G / Q000627:therapeutic use; D012189:Retrospective Studies; D012307:Risk Factors
chemical_list: D000900:Anti-Bacterial Agents; D010400:Penicillin G